X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13505) 13505
Newsletter (158) 158
Book Chapter (50) 50
Newspaper Article (28) 28
Magazine Article (21) 21
Dissertation (13) 13
Publication (6) 6
Conference Proceeding (4) 4
Reference (3) 3
Book / eBook (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7604) 7604
animals (7596) 7596
alzheimer's disease (5853) 5853
neurosciences (4148) 4148
alzheimers-disease (3791) 3791
mice (3409) 3409
male (2542) 2542
biochemistry & molecular biology (2512) 2512
amyloid beta-peptides - metabolism (2425) 2425
rats (2368) 2368
alzheimer disease - metabolism (2187) 2187
alzheimer disease - drug therapy (2148) 2148
amyloid precursor protein (1976) 1976
amyloid precursor protein secretases - antagonists & inhibitors (1815) 1815
brain (1782) 1782
amyloid beta-peptides - antagonists & inhibitors (1757) 1757
alzheimer’s disease (1700) 1700
female (1560) 1560
cells, cultured (1507) 1507
pharmacology & pharmacy (1505) 1505
proteins (1485) 1485
amyloid beta-protein (1409) 1409
cell biology (1379) 1379
neurology (1371) 1371
disease models, animal (1350) 1350
neurodegenerative diseases (1334) 1334
alzheimer disease - pathology (1293) 1293
oxidative stress (1286) 1286
mice, transgenic (1212) 1212
amyloid-beta (1182) 1182
alzheimers disease (1156) 1156
neurons - drug effects (1140) 1140
amyloid precursor protein secretases - metabolism (1135) 1135
inflammation (1125) 1125
amyloid (1124) 1124
a-beta (1096) 1096
neurons - metabolism (1081) 1081
neurons (1050) 1050
apoptosis (1011) 1011
analysis (1010) 1010
chemistry, medicinal (1002) 1002
expression (969) 969
brain - metabolism (966) 966
amyloid beta-protein precursor - metabolism (965) 965
neurodegeneration (964) 964
research (960) 960
mouse model (959) 959
dose-response relationship, drug (947) 947
enzyme inhibitors - pharmacology (942) 942
peptides (937) 937
mice, inbred c57bl (928) 928
transgenic mice (917) 917
amyloid beta-peptides - toxicity (895) 895
protein (886) 886
activation (861) 861
peptide fragments - metabolism (841) 841
neuroprotective agents - pharmacology (837) 837
β-amyloid (835) 835
dementia (827) 827
memory (819) 819
cell line, tumor (815) 815
alzheimer disease - physiopathology (775) 775
clinical neurology (772) 772
phosphorylation (771) 771
cell line (768) 768
signal transduction (768) 768
rats, sprague-dawley (765) 765
in-vitro (758) 758
in-vivo (752) 752
rodents (751) 751
disease (743) 743
pathology (737) 737
peptide fragments - antagonists & inhibitors (737) 737
structure-activity relationship (719) 719
neuroprotection (708) 708
alzheimer disease - genetics (702) 702
neurotoxicity (681) 681
physiological aspects (674) 674
amyloid beta-protein precursor - genetics (662) 662
long-term potentiation (662) 662
peptide (660) 660
aged (645) 645
hippocampus (645) 645
aspartic acid endopeptidases - antagonists & inhibitors (639) 639
cell survival - drug effects (639) 639
multidisciplinary sciences (632) 632
cognitive ability (616) 616
signal transduction - drug effects (611) 611
biomedicine (609) 609
drug design (604) 604
precursor protein (602) 602
amyloid beta-peptides - pharmacology (585) 585
brain - drug effects (564) 564
cells (562) 562
peptide fragments - pharmacology (561) 561
peptide fragments - toxicity (559) 559
brain - pathology (554) 554
central-nervous-system (553) 553
protein binding (552) 552
hippocampus - drug effects (548) 548
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13685) 13685
Japanese (86) 86
Chinese (56) 56
German (41) 41
Russian (18) 18
French (17) 17
Portuguese (7) 7
Norwegian (4) 4
Spanish (4) 4
Italian (3) 3
Hungarian (2) 2
Danish (1) 1
Dutch (1) 1
Greek (1) 1
Korean (1) 1
Slovak (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Trends in molecular medicine, ISSN 1471-4914, 2019, Volume 25, Issue 2, pp. 74 - 76
.... A new article in Cell Reports by Gunther and colleagues (Cell Rep. 2019; 26:145–158) shows that an orally administered cellular prion protein antagonist can rescue synaptic and cognitive deficits... 
cellular prion protein | Alzheimer’s disease | amyloid-β oligomers | cognition | antagonist | Alzheimer's disease | MEDICINE, RESEARCH & EXPERIMENTAL | BIOCHEMISTRY & MOLECULAR BIOLOGY | IMPAIRMENT | CELL BIOLOGY | Index Medicus | Amyloid-beta oligomers | Cognition | Antagonist | Cellular prion protein
Journal Article
Psychopharmacology, ISSN 0033-3158, 12/2014, Volume 231, Issue 24, pp. 4711 - 4722
Journal Article
CURRENT PHARMACEUTICAL DESIGN, ISSN 1381-6128, 2019, Volume 25, Issue 33, pp. 3506 - 3518
Journal Article
Experimental neurology, ISSN 0014-4886, 2007, Volume 203, Issue 1, pp. 241 - 245
Consumption of caffeine, an adenosine receptor antagonist, was found to be inversely associated with the incidence of Alzheimer's disease... 
Neuroprotection | Adenosine | receptor | Memory | Alzheimer's disease | β-amyloid | Caffeine
Journal Article
The Journal of neuroscience, ISSN 0270-6474, 03/2012, Volume 32, Issue 10, pp. 3492 - 3498
Journal Article
The Journal of biological chemistry, ISSN 1083-351X, 2016, Volume 291, Issue 7, pp. 3174 - 3183
Several different receptor proteins have been identified that bind monomeric, oligomeric, or fibrillar forms of amyloid-β (Aβ). "Good" receptors internalize Aβ... 
Neurons - pathology | Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors | PrPC Proteins - agonists | Apoptosis - drug effects | Humans | Receptors, N-Methyl-D-Aspartate - metabolism | Molecular Targeted Therapy | Receptors, Cell Surface - antagonists & inhibitors | Alzheimer Disease - pathology | Nerve Tissue Proteins - chemistry | Receptor Aggregation - drug effects | Protein Isoforms - metabolism | Protein Aggregation, Pathological - pathology | Alzheimer Disease - prevention & control | Protein Aggregation, Pathological - prevention & control | Protein Isoforms - chemistry | Amyloid beta-Peptides - metabolism | Neurons - metabolism | PrPC Proteins - metabolism | Neurons - drug effects | PrPC Proteins - antagonists & inhibitors | Protein Aggregates - drug effects | Nerve Tissue Proteins - antagonists & inhibitors | Receptor for Advanced Glycation End Products - metabolism | Receptors, Cell Surface - agonists | Alzheimer Disease - drug therapy | Low Density Lipoprotein Receptor-Related Protein-1 - metabolism | Nootropic Agents - therapeutic use | Receptors, Cell Surface - metabolism | Receptor for Advanced Glycation End Products - agonists | Protein Aggregation, Pathological - drug therapy | Nerve Tissue Proteins - metabolism | Amyloid beta-Peptides - antagonists & inhibitors | Animals | Low Density Lipoprotein Receptor-Related Protein-1 - agonists | Signal Transduction - drug effects | Models, Biological | Receptors, N-Methyl-D-Aspartate - agonists | Alzheimer Disease - metabolism | Ligands | Transcytosis - drug effects | Amyloid beta-Peptides - chemistry | Nootropic Agents - pharmacology | Protein Aggregation, Pathological - metabolism | Protein Isoforms - antagonists & inhibitors | Index Medicus | Minireviews | oligomer | prion | amyloid | receptor | Alzheimer disease
Journal Article
Journal Article
Biochemical and biophysical research communications, ISSN 0006-291X, 01/2014, Volume 443, Issue 3, pp. 1054 - 1059
Journal Article